Stock-Based Compensation (Tables)
|
9 Months Ended |
Sep. 30, 2026 |
|---|
| Share-Based Payment Arrangement [Abstract] |
|
| Schedule of Share-Based Payment Arrangement, Expensed and Capitalized, Amount |
The Company recorded stock-based compensation on the Consolidated Statement of Operations for the three and nine months ended September 30, 2026 and 2025 as follows (in thousands): | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended September 30, | | Nine Months Ended September 30, | | | 2026 | | 2025 | | 2026 | | 2025 | | Cost of revenue | | $ | 409 | | | $ | 336 | | | $ | 1,146 | | | $ | 1,054 | | | General and administrative | | 7,349 | | | 8,756 | | | 22,653 | | | 27,947 | | | Research and development | | 654 | | | 690 | | | 1,550 | | | 1,962 | | | Sales and marketing | | 425 | | | 523 | | | 1,340 | | | 2,311 | | | Total stock-based compensation | | $ | 8,837 | | | $ | 10,305 | | | $ | 26,689 | | | $ | 33,274 | |
|
| Schedule of Stock Option Activity |
A summary of the stock option activity under the Company’s plans for the nine months ended September 30, 2026 is as follows: | | | | | | | | | | | | | | | | | Number of
Shares | | Weighted Average Exercise Price | | Outstanding at December 31, 2025 | | 7,162,201 | | | $ | 13.58 | | | Granted | | 3,183,559 | | | $ | 10.91 | | | | | | | | Exercised | | (1,213,820) | | | $ | 11.90 | | | Forfeited | | (1,130,186) | | | $ | 14.04 | | | Outstanding at September 30, 2026 | | 8,001,754 | | | $ | 12.70 | | | Vested and expected to vest at September 30, 2026 | | 8,001,754 | | | $ | 12.70 | | | Exercisable at September 30, 2026 | | 3,218,264 | | | $ | 14.82 | |
|
| Schedule of Fair Value of Each Stock Option Award Granted |
The fair value of each stock option award granted during the nine months ended September 30, 2026 was estimated as of the grant date using a Black-Scholes model with the following assumptions: | | | | | | | Nine Months Ended
September 30, 2026 | | Expected term (in years) | 5.2 - 6.5 | | Risk-free interest rate (%) | 3.5% - 4.6% | | Expected volatility (%) | 62.4% - 68.3% | | Dividend yield (%) | — | | Weighted average grant date fair value per share | $6.28 |
|
| Schedule of Restricted Stock Activity |
A summary of the restricted stock activity under the Company’s plans for the nine months ended September 30, 2026 is as follows: | | | | | | | | | | | | | | | | | Number of Restricted
Shares | | Weighted Average Grant Date Fair Value | | Nonvested at December 31, 2025 | | 2,829,597 | | | $ | 11.89 | | | Granted | | 2,042,339 | | | $ | 10.32 | | | Vested | | (1,501,516) | | | $ | 12.09 | | | Forfeited | | (403,259) | | | $ | 11.90 | | | Nonvested at September 30, 2026 | | 2,967,161 | | | $ | 10.71 | |
A summary of the PSU activity under the Company’s plans for the nine months ended September 30, 2026 is as follows:
| | | | | | | | | | | | | | | | | Number of Stock Units | | Weighted Average Grant Date Fair Value | | Nonvested at December 31, 2025 | | 552,208 | | | $ | 19.38 | | | Granted | | — | | | $ | — | | | Vested | | — | | | $ | — | | | Forfeited | | (241,492) | | | $ | 21.82 | | | Nonvested at September 30, 2026 | | 310,716 | | | $ | 17.48 | |
|